Abstract:α-Synuclein (α-syn) fibrillar aggregates are the major component of Lewy bodies and Lewy neurites presenting as the pathology hallmark of Parkinson’s disease (PD). Studies have shown that α-syn is potential to form different conformational fibrils associated with different synucleinopathies, but whether the conformation of α-syn fibrils changes in different phases of related diseases is to be explored. Here, we amplified α-syn aggregates from the cerebrospinal fluid (CSF) of preclinical (pre-PD) and late-stage postmortem PD (post-PD) patients. Our results show that compared to the CSF of pre-PD, that of post-PD is markedly stronger in seeding in vitro α-syn aggregation, and the amplified fibrils are more potent in inducing endogenous α-syn aggregation in neurons. Cryo-electron microscopic structures further reveal that the difference between the pre-PD- and post-PD-derived fibrils lies on a minor polymorph which in the pre-PD fibrils is morphologically straight, while in the post-PD fibrils represents a single protofilament assembled by a distinctive conformation of α-syn. Our work demonstrates structural and pathological differences between pre-PD and post-PD α-syn aggregation and suggests potential alteration of α-syn fibrils during the progression of PD clinical phases. Significance Statement Increasing evidence support different conformational α-syn fibrils in patients with different α-synucleinopathies, but whether the conformation of α-syn fibrils changes in different phases of related diseases is unknown. Here, we show that α-syn fibrils amplified from the cerebrospinal fluid (CSF) of the late-stage postmortem PD (post-PD) patient are more potent in inducing endogenous α-syn aggregation in neurons than that amplified from the preclinical (pre-PD) patient. Cryo-EM structures further reveal that the post-PD fibrils contain a novel conformation that is distinct from either the pre-PD fibrils or those previously reported. Our work suggests conformational evolution of α-syn fibrils along with PD progression. ### Competing Interest Statement The authors have declared no competing interest.

Heparin induces α-synuclein to form new fibril polymorphs with attenuated neuropathology

Time-course remodeling and pathology intervention of α-synuclein amyloid fibril by heparin and heparin-like oligosaccharides

Different Charged Biopolymers Induce Α-Synuclein to Form Fibrils with Distinct Structures

Amyloid fibril structure of α-synuclein determined by cryo-electron microscopy

Structural polymorphism of alpha-synuclein fibrils alters pathway of Hsc70 mediated disaggregation

Amyloid accelerator polyphosphate fits as the mystery density in α-synuclein fibrils

Phosphorylation and O-GlcNAcylation at the Same Α-Synuclein Site Generate Distinct Fibril Structures

Amyloid Accelerator Polyphosphate Implicated as the Mystery Density in α-Synuclein Fibrils

Conformational change of α-synuclein fibrils in cerebrospinal fluid from different clinical phases of Parkinson's disease

Unravelling heparin's enhancement of amyloid aggregation in a model peptide system

Binding adaptability of chemical ligands to polymorphic α-synuclein amyloid fibrils

Parkinson's disease-related phosphorylation at Tyr39 rearranges α-synuclein amyloid fibril structure revealed by cryo-EM.

Structural Insights of Fe 3+ Induced α-synuclein Fibrillation in Parkinson's Disease

Parkinson’s disease associated mutation E46K of α-synuclein triggers the formation of a novel fibril structure

Heparin Remodels the Microtubule-Binding Repeat R3 of Tau Protein Towards Fibril-Prone Conformations

Structural Insights into α-Synuclein Fibril Polymorphism: Effects of Parkinson's Disease-Related C-Terminal Truncations

High-speed Atomic Force Microscopy Reveals Structural Dynamics of Α-Synuclein Monomers and Dimers.

Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases

Inhibition of Α‐synuclein Fibrillization by Dopamine Analogs Via Reaction with the Amino Groups of Α‐synuclein

Different structures and pathologies of α-synuclein fibrils derived from preclinical and postmortem patients of Parkinson’s disease

Cryo-EM structure of alpha-synuclein fibrils amplified by PMCA from PD and MSA patient brains